HEC-93077

东健顺

Report date: 2025/11/06 15:48:55
NME

Base Information

Drug NameHEC-93077
Drug Alias NameHEC-93077HEC93077
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUric acid transporter 1 inhibitorsXanthine dehydrogenase inhibitors
TargetsUric acid transporter 1Xanthine dehydrogenase
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperuricemiaGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A